Acorah Software Products - Accounts Production 16.4.675 false true 30 November 2023 1 December 2022 false 1 December 2023 30 November 2024 30 November 2024 11659157 Mr Dan Portess iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11659157 2023-11-30 11659157 2024-11-30 11659157 2023-12-01 2024-11-30 11659157 frs-core:CurrentFinancialInstruments 2024-11-30 11659157 frs-core:ComputerEquipment 2024-11-30 11659157 frs-core:ComputerEquipment 2023-12-01 2024-11-30 11659157 frs-core:ComputerEquipment 2023-11-30 11659157 frs-core:FurnitureFittings 2024-11-30 11659157 frs-core:FurnitureFittings 2023-12-01 2024-11-30 11659157 frs-core:FurnitureFittings 2023-11-30 11659157 frs-core:ShareCapital 2024-11-30 11659157 frs-core:RetainedEarningsAccumulatedLosses 2024-11-30 11659157 frs-bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 11659157 frs-bus:FilletedAccounts 2023-12-01 2024-11-30 11659157 frs-bus:SmallEntities 2023-12-01 2024-11-30 11659157 frs-bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 11659157 frs-bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 11659157 frs-bus:Director1 2023-12-01 2024-11-30 11659157 frs-countries:EnglandWales 2023-12-01 2024-11-30 11659157 2022-11-30 11659157 2023-11-30 11659157 2022-12-01 2023-11-30 11659157 frs-core:CurrentFinancialInstruments 2023-11-30 11659157 frs-core:ShareCapital 2023-11-30 11659157 frs-core:RetainedEarningsAccumulatedLosses 2023-11-30
Registered number: 11659157
Portess Medical Writing Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 11659157
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 4,263 5,330
4,263 5,330
CURRENT ASSETS
Debtors 5 90,318 119,670
Cash at bank and in hand 791,728 634,089
882,046 753,759
Creditors: Amounts Falling Due Within One Year 6 (59,913 ) (82,369 )
NET CURRENT ASSETS (LIABILITIES) 822,133 671,390
TOTAL ASSETS LESS CURRENT LIABILITIES 826,396 676,720
PROVISIONS FOR LIABILITIES
Deferred Taxation (1,066 ) (1,333 )
NET ASSETS 825,330 675,387
CAPITAL AND RESERVES
Called up share capital 1 1
Profit and Loss Account 825,329 675,386
SHAREHOLDERS' FUNDS 825,330 675,387
Page 1
Page 2
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Dan Portess
Director
24 April 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Portess Medical Writing Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11659157 . The registered office is 7 Christie Way, Christie Fields, Manchester, M21 7QY.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the FRS 102 Section 1A Small Entities - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the entity
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 20% Reducing Balance
Computer Equipment 20% Reducing Balance
2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 1)
2 1
Page 3
Page 4
4. Tangible Assets
Fixtures & Fittings Computer Equipment Total
£ £ £
Cost
As at 1 December 2023 250 7,988 8,238
As at 30 November 2024 250 7,988 8,238
Depreciation
As at 1 December 2023 166 2,742 2,908
Provided during the period 17 1,050 1,067
As at 30 November 2024 183 3,792 3,975
Net Book Value
As at 30 November 2024 67 4,196 4,263
As at 1 December 2023 84 5,246 5,330
5. Debtors
2024 2023
£ £
Due within one year
Trade debtors 20,622 61,583
Amounts owed by group undertakings 14,973 7,000
Other debtors 54,723 51,087
90,318 119,670
6. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 5,910 10,232
Other creditors 1,540 520
Taxation and social security 52,463 71,617
59,913 82,369
Page 4